Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RING: Rituximab for Refractory Lupus Nephritis
NCT01673295Phase 3Unknown
- Start
- Nov 2014
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in lupus nephritis (LN). Status: unknown.
02
Drugs
rituximab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01673295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673295.